E&Y appointed to sell Park Row
Royal Liver engages Ernst & Young to sell Park Row
Liverpool-based assurance and life society Royal Liver has appointed Ernst
& Young to sell Park Row, its financial advisory practice.
Royal Liver acquired the loss-making business for £16.7m in 2003. Park Row
posted an operating loss of nearly £6m in 2008, despite completing a successful
cost-cutting program to save £11m.
Park Row is being investigated by the Financial Services Authority (FSA),
which is reviewing its systems and controls.